BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7872723)

  • 1. Characterization of p53 gene mutations in colorectal carcinomas from an Asian population.
    Shi CY; Phang TW; Ngoi SS; Wee A; Li B; Lin Y; Lee HP; Ong CN
    Anticancer Res; 1994; 14(6B):2811-6. PubMed ID: 7872723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer.
    Catalano T; Curia MC; Aceto G; Verginelli F; Cascinu S; Cama A; Mariani-Costantini R; Teti D; Battista P
    Oncol Rep; 2005 Sep; 14(3):625-31. PubMed ID: 16077965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased incidence of p53 mutations is associated with hepatic metastasis in colorectal neoplastic progression.
    Kastrinakis WV; Ramchurren N; Rieger KM; Hess DT; Loda M; Steele G; Summerhayes IC
    Oncogene; 1995 Aug; 11(4):647-52. PubMed ID: 7651727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations of the K-ras and p53 genes in gastric adenocarcinomas from a high-incidence region around Florence, Italy.
    Hongyo T; Buzard GS; Palli D; Weghorst CM; Amorosi A; Galli M; Caporaso NE; Fraumeni JF; Rice JM
    Cancer Res; 1995 Jun; 55(12):2665-72. PubMed ID: 7780983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
    Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
    Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological study of p53 tumor suppressor gene mutations in patients from Luxembourg and the German Saar region with an advanced colorectal cancer using PCR-SSCP analysis.
    Pauly M; Schmitz M; Kayser I; Lagoda P; Türeci O; Kerschen A; Weber J; Seitz G; Hentges F; Dicato M
    Biomed Pharmacother; 1998; 52(5):220-8. PubMed ID: 9755819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China.
    Gao H; Wang LD; Zhou Q; Hong JY; Huang TY; Yang CS
    Cancer Res; 1994 Aug; 54(16):4342-6. PubMed ID: 8044781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discordance of p53 mutations of synchronous colorectal carcinomas.
    Eguchi K; Yao T; Konomoto T; Hayashi K; Fujishima M; Tsuneyoshi M
    Mod Pathol; 2000 Feb; 13(2):131-9. PubMed ID: 10697269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene.
    Yamada K; Zhong X; Kanazawa S; Koike J; Tsujita K; Hemmi H
    Oncol Rep; 2003; 10(4):859-66. PubMed ID: 12792735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of p53 gene mutations in a Brazilian population with oral squamous cell carcinomas.
    Chaves AC; Cherubini K; Herter N; Furian R; Santos DS; Squier C; Domann FE
    Int J Oncol; 2004 Feb; 24(2):295-303. PubMed ID: 14719105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Androgen receptor gene mutations and p53 gene analysis in advanced prostate cancer].
    Castagnaro M; Yandell DW; Dockhorn-Dworniczak B; Wolfe HJ; Poremba C
    Verh Dtsch Ges Pathol; 1993; 77():119-23. PubMed ID: 7511268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of p53 mutations in colorectal liver metastases and correlation with clinical parameters.
    Tullo A; D'Erchia AM; Honda K; Mitry RR; Kelly MD; Habib NA; Saccone C; Sbisà E
    Clin Cancer Res; 1999 Nov; 5(11):3523-8. PubMed ID: 10589767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas.
    Weyrer K; Feichtinger H; Haun M; Weiss G; Ofner D; Weger AR; Umlauft F; Grünewald K
    Lab Invest; 1996 Jan; 74(1):279-89. PubMed ID: 8569192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas.
    Komuro H; Hayashi Y; Kawamura M; Hayashi K; Kaneko Y; Kamoshita S; Hanada R; Yamamoto K; Hongo T; Yamada M
    Cancer Res; 1993 Nov; 53(21):5284-8. PubMed ID: 8221663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 alterations are associated with improved prognosis in distal colonic carcinomas.
    Soong R; Grieu F; Robbins P; Dix B; Chen D; Parsons R; House A; Iacopetta B
    Clin Cancer Res; 1997 Aug; 3(8):1405-11. PubMed ID: 9815825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [p53 gene point mutation in human colorectal carcinoma].
    Xu W; Yang D; Wan Y
    Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):328-31. PubMed ID: 8697967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations of the p53 gene in the stool of patients with resectable colorectal cancer.
    Eguchi S; Kohara N; Komuta K; Kanematsu T
    Cancer; 1996 Apr; 77(8 Suppl):1707-10. PubMed ID: 8608566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of p53 gene mutations in primary neuroblastomas.
    Vogan K; Bernstein M; Leclerc JM; Brisson L; Brossard J; Brodeur GM; Pelletier J; Gros P
    Cancer Res; 1993 Nov; 53(21):5269-73. PubMed ID: 8221661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms and probable lack of mutation in the WAF1-CIP1 gene in colorectal cancer.
    Li YJ; Laurent-Puig P; Salmon RJ; Thomas G; Hamelin R
    Oncogene; 1995 Feb; 10(3):599-601. PubMed ID: 7845685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.